N- (carboxymethyl)- N- (phosphonomethyl)- 5- aminoshikimate- 3- phosphate

inhibitor of 5-enolpyruvoylshikimate-3-phosphate synthase (EC 2.5.1.19)

Also Known As:

3-(phosphonooxy)-4-hydroxy-5-(N-(phosphonomethyl-2-oxoethyl)amino)-1-cyclohexene-1-carboxylic acid; CPASP

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Almomani, Ahmed: 1 article (06/2018)
2.	Bhatti, Sabha: 1 article (06/2018)
3.	Duarte, Andres: 1 article (06/2018)
4.	Gurram, Pooja: 1 article (06/2018)
5.	Habash, Fuad: 1 article (06/2018)
6.	Hakeem, Abdul: 1 article (06/2018)
7.	Vallurupalli, Srikanth: 1 article (06/2018)

1.	Liver Diseases (Liver Disease) 06/01/2018 - "Compared with other disease states, ePASP correlates modestly with cPASP in patients with advanced liver disease. "